On July 6, the 2024 Academic Conference of the Endocrinology Committee of the Qingdao Association of Integrated Chinese and Western Medicine, organized by the Qingdao Association of Integrated Chinese and Western Medicine and hosted by Qilu Hospital of Shandong University (Qingdao), was held in Qingdao. Professor Liu Yuantao, Chairman of the Endocrinology Committee of the Qingdao Association of Integrated Chinese and Western Medicine and faculty member of Qilu Hospital of Shandong University (Qingdao), served as the conference chair. Professor Wang Sixuan of Beijing China-Japan Friendship Hospital, Professor Wang Yangang of the Affiliated Hospital of Qingdao University Medical College, Professor Guan Qingbo of Shandong Provincial Hospital Affiliated to Shandong First Medical University, Professor Wang Furong of the School of Traditional Chinese Medicine at Shandong University of Traditional Chinese Medicine, and other experts in Chinese and Western medicine attended the conference and delivered academic keynote presentations. As a contracted Medical Consortium partner of Qilu Hospital of Shandong University (Qingdao), President Wang Tiemin and President Zhang Xin'an of Qingdao Jingkang TCM Nephrology Hospital were invited to attend and co-chair the thematic symposium on "Prospects for Integrated Chinese-Western Medicine in Extending the Honeymoon Period of Diabetes," engaging in academic exchange and discussion with numerous experts and colleagues in Chinese and Western medicine from within and outside Shandong Province.
Committee members of the Endocrinology Committee of the Qingdao Association of Integrated Chinese and Western Medicine, candidates for the Obesity Study Group, and experts and core staff from medical institutions at all levels across the city engaged in the field of integrated Chinese-Western medicine for endocrinology and diabetes were all in attendance. The conference aimed to leverage the influence of the association, continuously strengthen academic exchanges within the industry, and further improve the diagnostic and treatment standards of integrated Chinese-Western medicine for endocrinology and diabetes through mutual learning and exchange of research achievements and clinical experience, thereby promoting the development of integrated Chinese-Western medicine in endocrinology in Qingdao.
During the thematic academic exchange session, President Wang Tiemin and President Zhang Xin'an were invited to co-chair the symposium on "Prospects for Integrated Chinese-Western Medicine in Extending the Honeymoon Period of Diabetes," engaging in thorough exchange and in-depth discussion with academic presenter Professor Wang Sixuan of Beijing China-Japan Friendship Hospital and other participants on the timely implementation of comprehensive systemic reversal treatment for early-stage (prediabetic) diabetes. President Wang Tiemin and President Zhang Xin'an shared and discussed Jingkang TCM's diagnostic and treatment techniques and experience in the integrated Chinese-Western medical prevention and treatment of diabetic nephropathy with the attending experts, receiving widespread recognition and affirmation.
In addition, Professor Liu Yuantao, Chairman of the Endocrinology Committee of the Qingdao Association of Integrated Chinese and Western Medicine, president of this conference, Distinguished Expert of Jingkang TCM, and faculty member of Qilu Hospital of Shandong University (Qingdao), delivered a keynote academic report titled "Refocusing on the Origin of Disease Mechanisms: Redefining Diabetes Treatment," sharing insights from the frontiers of medicine and clinical experience. He also presided over the closing ceremony of the conference.
As a contracted Medical Consortium partner of Qilu Hospital of Shandong University (Qingdao), Qingdao Jingkang TCM Nephrology Hospital continues to broaden its disciplinary development. While strengthening its foundation in nephrology, the hospital further enhances precise diagnosis and treatment while expanding into endocrine and metabolic diseases such as diabetes and gout, as well as hypertension and cardiovascular-cerebrovascular rehabilitation. The hospital collaborates with Qilu Hospital (Qingdao) to explore a new Medical Consortium service model of "Major Specialty + Strong Comprehensive Care." Over more than two decades since its establishment, driven by academically-led integrative innovation and continuously improving diagnostic and treatment standards, the hospital has been successively approved as a member unit of the Heart Failure Specialized Disease Consortium of the National Center for Cardiovascular Diseases, a sub-center of the Hypertension Specialized Disease Consortium of the National Center for Cardiovascular Diseases, a Diabetes Specialist Development Unit of the Shandong Provincial Medical Association, and a member unit of the Shandong Provincial Primary Expert Alliance for Endocrine and Metabolic Diseases. These achievements have played a positive role in the continuous enhancement of diagnostic and treatment capabilities and have laid a solid foundation for the hospital's high-quality development.